CORRESP Filing
ARTELO BIOSCIENCES, INC.
Date: Dec. 1, 2025 · CIK: 0001621221 · Accession: 0001640334-25-002233
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291597
Letter
wordproof.doc December 1, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Doris Stacey Gama Re: Artelo Biosciences Inc. Registration Statement on Form S-1 File No. 333-291597 Acceleration Request Requested Date: December 2, 2025 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. (the “ Company ”) hereby requests that its Registration Statement on Form S-1 (File No. 333-291597) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Robert Wernli at (619) 361-4805. Sincerely, ARTELO BIOSCIENCES, INC. By: /s/ Gregory D. Gorgas Gregory D. Gorgas President and Chief Executive Officer cc: Martin J. Waters, Wilson Sonsini Goodrich & Rosati, P.C. Robert Wernli, Wilson Sonsini Goodrich & Rosati, P.C.
Show Raw Text
CORRESP 1 filename1.htm wordproof.doc December 1, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Doris Stacey Gama Re: Artelo Biosciences Inc. Registration Statement on Form S-1 File No. 333-291597 Acceleration Request Requested Date: December 2, 2025 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. (the “ Company ”) hereby requests that its Registration Statement on Form S-1 (File No. 333-291597) (the “ Registration Statement ”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Robert Wernli at (619) 361-4805. Sincerely, ARTELO BIOSCIENCES, INC. By: /s/ Gregory D. Gorgas Gregory D. Gorgas President and Chief Executive Officer cc: Martin J. Waters, Wilson Sonsini Goodrich & Rosati, P.C. Robert Wernli, Wilson Sonsini Goodrich & Rosati, P.C.